Syndecan-1 inhibition promotes anti-tumor immune response and facilitates the efficacy of anti-PD1 checkpoint immunotherapy (kdSdc1 and mutant)

ABSTRACT: To investigate the function of SDC1 in the regulation of anti-tumor immunity, we established B16 and MC38 cell lines in which sdc1 or control RNA has been knocked down by shRNA.

ORGANISM(S): Mus musculus

PROVIDER: GSE254619 | GEO | 2024/09/18

REPOSITORIES: GEO